Indication
Infantile Spasms
3 clinical trials
2 products
Product
GanaxoloneClinical trial
A Double-blind, Placebo-controlled, Dose-ranging Clinical Study to Evaluate the Safety, Tolerability, and Antiepileptic Activity of Ganaxolone in Treatment of Patients With Infantile SpasmsStatus: Completed, Estimated PCD: 2008-05-01
Clinical trial
An Open-label Clinical Study to Evaluate the Safety and Antiepileptic Activity of Ganaxolone in Treatment of Patients Diagnosed With Infantile Spasms.Status: Terminated, Estimated PCD: 2009-03-01
Product
JBPOS0101Clinical trial
A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms PatientsStatus: Terminated, Estimated PCD: 2021-12-10